Insmed Inc
NASDAQ:INSM
Intrinsic Value
The intrinsic value of one
INSM
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 152.44 USD,
Insmed Inc
is
hidden
.
Valuation History
Insmed Inc
INSM looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether INSM usually does or if today's premium is unusual.
Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Insmed Inc.
Fundamental Analysis
Arikayce drives most of the company’s current revenue, leaving Insmed vulnerable to market changes or competing treatments that could quickly erode its core earnings base.
Continued geographic expansion and potential label extensions for Arikayce could substantially increase its patient reach, reinforcing revenue growth and reducing the company’s reliance on additional funding.
Revenue & Expenses Breakdown
Insmed Inc
Earnings Waterfall
Insmed Inc
Wall St
Price Targets
INSM Price Targets Summary
Insmed Inc
According to Wall Street analysts, the average 1-year price target for
INSM
is 219.19 USD
with a low forecast of 163.62 USD and a high forecast of 253.05 USD.
The intrinsic value of one
INSM
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 152.44 USD,
Insmed Inc
is
hidden
.